Chapter 12: From Marshall Hicks, MD as Interim President to Peter Pisters, MD

Chapter 12: From Marshall Hicks, MD as Interim President to Peter Pisters, MD

Files

Loading...

Media is loading
 

Description

[pause in recording]

Dr. Tweardy explains that the research community has been waiting to see evidence of Dr. Pister’s commitment to the research agenda, and his appointment of Guilio Draetta as Chief Scientific Officer has begun to address this challenge

Next, Dr. Tweardy comments on Dr. Pister’s slow and deliberate decision making style. He then comments on the tradition of long-tenured presidents at the institution.

Identifier

TweardyDJ_03_20190418_C12

Publication Date

4-18-2019

Publisher

The Historical Resources Center, Research Medical Library, The University of Texas Cancer Center

City

Houston, Texas

Topic Covered

The Interview Subject's Story - Overview; Leadership; On Leadership; Working Environment; Building/Transforming the Institution; Growth and/or Change; Obstacles, Challenges; Institutional Politics; Controversy; MD Anderson Culture; Portraits; The Business of MD Anderson; The Institution and Finances

Creative Commons License

Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.

Disciplines

History of Science, Technology, and Medicine | Oncology | Oral History

Transcript

Tacey. A. Rosolowski, PhD:

Conditions Governing Access

Open

Chapter 12: From Marshall Hicks, MD as Interim President to Peter Pisters, MD

Share

COinS
 

Accessibility Statement

This item was created prior to May 2026. It is preserved for research, reference, or historical recordkeeping. Following WCAG 2.1, the library may provide accessible versions of archival materials upon request. For accommodation requests please submit an accessibility request form.